E. Hindmarsh

Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells.

R. Marks, E. Hindmarsh, 1998, Journal of immunology.

Decay‐accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C

R. Marks, E. Hindmarsh, 1998, European journal of immunology.

Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis.

Paul N. Smith, C. Parish, Di Yu, 2008, Arthritis and rheumatism.

Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor

Jeffrey W. Smith, C. D. Browne, E. Hindmarsh, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cell surface expression of the 300 kDa mannose‐6‐phosphate receptor by activated T lymphocytes

C. Parish, D. Willenborg, M. Staykova, 2001, Immunology and cell biology.

CellsRetraction or Removal of Overlying Endothelial Extracellular Matrix In Vitro and Is Initiated by Complement Activation Occurs on Subendothelial

R. Marks, E. Hindmarsh, 1998 .

Treatment of central nervous system inflammation with inhibitors of basement membrane degradation

W. Cowden, C. Parish, D. Willenborg, 1998, Immunology and cell biology.

5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: purification, pH dependence, and inhibitors.

R. Christopherson, L. Phillips, R. Duggleby, 1994, Biochemistry.

Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes.

Karen L. Bunting, A. Kelleher, P. Milburn, 2011, Molecular cell.